Loading...

NEXTGEN HEREDITARY CANCER PANEL, EDTA BLOOD

image not found

NABL Cap Accredited 
The NextGen Hereditary Cancer Panel is an advanced genetic test designed to detect inherited gene mutations that increase the risk of various cancers. It analyzes multiple high-impact genes using next-generation sequencing for comprehensive assessment. Metropolis Healthcare ensures precise mutation detection with robust quality controls and expert genomic reporting. This panel supports early risk identification, preventive planning, and personalized clinical management

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 18,000.00

Sample Type: EDTA Blood

Fasting Not Required


Booking Procedure:
  1. Technician from Metropolis will be assigned for a home sample collection after booking confirmation.
  2. Sample will be collected by our technician at your address at given slot.
  3. You can make the payment to the technician at the time of collection
  4. Your sample will then be transported to the nearest collection center and will be centrifuged before sending to the lab for processing.
  5. Soft copy reports will be sent to your email address within 24 to 48 hours or as per defined TAT for Tests.

Frequently Asked Questions (FAQ's):

What does the NextGen Hereditary Cancer Panel include?
It includes next-generation sequencing of multiple genes associated with hereditary cancers such as breast, ovarian, colorectal, and others.

How does Metropolis Healthcare perform this genetic test?
Metropolis Healthcare uses high-depth NGS technology with stringent validation to ensure accurate detection of pathogenic variants.

Who should take this test?
Individuals with a family history of cancer, early-onset cancers, or clinicians recommending genetic risk assessment may need this panel.

What sample is required for this test?
A blood sample collected in an EDTA vial is used for DNA extraction and analysis.

How do the results help in cancer prevention?
Results can identify inherited mutations, enabling timely surveillance, lifestyle modifications, and risk-reduction strategies.

Are the results reliable at Metropolis Healthcare?
Yes, Metropolis Healthcare follows global standards, expert analysis, and multi-step verification for dependable genetic reporting.

Can this test guide treatment decisions?
In some cases, inherited mutations can influence targeted therapies or surgical planning.

Why choose Metropolis Healthcare for hereditary cancer testing?

Because Metropolis Healthcare offers advanced genomic technology, precise interpretation, and trusted clinical support 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab